Case 4: Melissa, a 20-year-old college student presenting for evaluation of some painless "growths" on her genitals.
Goal: To improve health care providers' ability to recognize, diagnose and treat HPV.
- Identify risk factors for genital HPV.
- Describe the clinical manifestations of genital HPV.
- List the current diagnostic methods for genital HPV.
- List the potential implications for HPV DNA testing.
- Explain the treatment options for genital warts.
- Deliver appropriate counseling messages to women with genital warts and cervical dysplasia.
- Explain options for partner management for women with genital warts and cervical dysplasia.
- Explain how Stage-based Behavioral Counseling can be used for STD/HIV risk reduction.
Clinical content
Clinical content for this case was developed by Bethany Weaver, DO, MPH, Acting Instructor, Department of Medicine, University of Washington and Faculty Member, Seattle STD/HIV Prevention Training Center.
Risk Reduction content
Content on risk reduction was developed by Patricia Coury-Doniger, MS, FNP and Peter McGrath BA of the New York State STD/HIV Prevention Training Center - Rochester.
Partner Management content
Content on Partner Management was developed by Tammy Foskey, MA, Assistant Director of the Texas STD/HIV Prevention Training Center and Sue Anne Payette, MS, Training Director, of the New York State STD/HIV Prevention Training Center.
CDC, our planners, and our content experts wish to disclose they have no
financial interests or other relationships with the manufactures of
commercial products, suppliers of commercial services, or commercial
supporters with the exception of Dr. Bethany Weaver and she wishes to
disclose:
Merck, Inc. Consultant and Young Adult Primary Care Advisory Board
Member Re: prophylactic HPV vaccine
Presentations will not include any discussion of the unlabeled use of a
product or a product under investigational use.
- Rheta Barnes, MSN, MPH, Health Education Specialist, Medical Education and Evaluation, Division of STD Prevention, National Center for HIV, STD and TB Prevention, CDC
- Kimberly Berkhoudt, MS, NP Infectious Diseases Unit, University of Rochester and Faculty Member, New York State STD/HIV Prevention Training Center-Rochester
- Eileen Dunne, MD, MPH, Medical Officer, Division of STD Prevention, National Center for HIV, STD and TB Prevention, CDC
- Annekathryn Goodman, MD, Director, Fellowship in Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School
- Danuta Kasprzyk, BS, MA, PhD, Research Leader, Centers for Public Health Research and Evaluation, Battelle Seattle Research Center
- Laura Koutsky, PhD, Professor of Epidemiology, University of Washington
- Lois Lux, MS, RN International Training and Education Center on HIV (I-TECH)
- Sylvie Ratelle, MD, MPH, Medical Director, Division of STD Prevention, Massachusetts Department of Public Health, Medical Director of the STD/HIV Prevention Training Center of New England and Assistant Professor of Family Medicine and Community Health, University of Massachusetts Medical School
- Maureen Scahill MS, NP , New York State STD/HIV Prevention Training Center - Rochester
- Michael Stern, MN, ARNP, HPV Research Clinician, University of Washington
Seattle STD/HIV Prevention Training Center,
University of Washington
Henry Sobel, President, Huge Media, Berkeley, California
California STD/HIV Prevention Training Center, California Department of
Health Services
New England STD/HIV Prevention Training Center, Massachusetts Department of
Public Health
Seattle STD/HIV Prevention Training Center, University of Washington
This project was made possible through funding by the Centers for Disease
Control and Prevention.